Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1969 1
1977 1
1982 1
1983 2
1984 2
1985 2
1986 1
1987 2
1988 2
1989 1
1990 4
1991 1
1992 10
1993 4
1994 12
1995 16
1996 7
1997 4
1998 8
1999 19
2000 10
2001 12
2002 15
2003 6
2004 13
2005 12
2006 14
2007 14
2008 13
2009 17
2010 15
2011 8
2012 12
2013 13
2014 9
2015 8
2016 7
2017 4
2018 7
2019 5
2020 10
2021 6
2022 7
2023 13
2024 16
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

353 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Maurer M, et al. Lancet. 2024 Jan 13;403(10422):147-159. doi: 10.1016/S0140-6736(23)01684-7. Epub 2023 Nov 23. Lancet. 2024. PMID: 38008109 Clinical Trial.
Targeting neuronal lysosomal dysfunction caused by β-glucocerebrosidase deficiency with an enzyme-based brain shuttle construct.
Gehrlein A, Udayar V, Anastasi N, Morella ML, Ruf I, Brugger D, von der Mark S, Thoma R, Rufer A, Heer D, Pfahler N, Jochner A, Niewoehner J, Wolf L, Fueth M, Ebeling M, Villaseñor R, Zhu Y, Deen MC, Shan X, Ehsaei Z, Taylor V, Sidransky E, Vocadlo DJ, Freskgård PO, Jagasia R. Gehrlein A, et al. Among authors: von der mark s. Nat Commun. 2023 Apr 12;14(1):2057. doi: 10.1038/s41467-023-37632-4. Nat Commun. 2023. PMID: 37045813 Free PMC article.
30-day Morbidity and Mortality after Cholecystectomy for Benign Gallbladder Disease (AMBROSE): A Prospective, International Collaborative Cohort Study.
Wong GYM, Wadhawan H, Roth Cardoso V, Bravo Merodio L, Rajeev Y, Maldonado RD, Martinino A, Balasubaramaniam V, Ashraf A, Siddiqui A, Al-Shkirat AG, Mohammed Abu-Elfatth A, Gupta A, Alkaseek A, Ouyahia A, Said A, Pandey A, Kumar A, Maqbool B, Millán CA, Singh C, Pantoja Pachajoa DA, Adamovich DM, Petracchi E, Ashraf F, Clementi M, Mulita F, Marom GA, Abdulaal G, Verras GI, Calini G, Moretto G, Elfeki H, Liang H, Jalaawiy H, Elzayat I, Das JK, Aceves-Ayala JM, Ahmed KT, Degrate L, Aggarwal M, Omar MA, Rais M, Elhadi M, Sakran N, Bhojwani R, Agarwalla R, Kanaan S, Erdene S, Chooklin S, Khuroo S, Dawani S, Asghar ST, Fung TKJ, Omarov T, Grigorean VT, Boras Z, V Gkoutos G, Singhal R, Mahawar K; AMBROSE Collaborative. Wong GYM, et al. Ann Surg. 2025 Feb;281(2):312-321. doi: 10.1097/SLA.0000000000006236. Epub 2024 Feb 13. Ann Surg. 2025. PMID: 38348652 Free PMC article.
Minimal manifestation status and prednisone withdrawal in the MGTX trial.
Lee I, Kuo HC, Aban IB, Cutter GR, McPherson T, Kaminski HJ, Sussman J, Ströbel P, Oger J, Cea G, Heckmann JM, Evoli A, Nix W, Ciafaloni E, Antonini G, Witoonpanich R, King JO, Beydoun SR, Chalk CH, Barboi AC, Amato AA, Shaibani AI, Katirji B, Lecky BRF, Buckley C, Vincent A, Dias-Tosta E, Yoshikawa H, Waddington-Cruz M, Pulley MT, Rivner MH, Kostera-Pruszczyk A, Pascuzzi RM, Jackson CE, Verschuuren JJG, Massey JM, Kissel JT, Werneck LC, Benatar M, Barohn RJ, Tandan R, Mozaffar T, Conwit R, Minisman G, Sonett JR, Wolfe GI; MGTX study group. Lee I, et al. Neurology. 2020 Aug 11;95(6):e755-e766. doi: 10.1212/WNL.0000000000010031. Epub 2020 Jul 1. Neurology. 2020. PMID: 32611638 Free PMC article. Clinical Trial.
A joint international consensus statement for measuring quality of survival for patients with childhood cancer.
van Kalsbeek RJ, Hudson MM, Mulder RL, Ehrhardt M, Green DM, Mulrooney DA, Hakkert J, den Hartogh J, Nijenhuis A, van Santen HM, Schouten-van Meeteren AYN, van Tinteren H, Verbruggen LC, Conklin HM, Jacola LM, Webster RT, Partanen M, Kollen WJW, Grootenhuis MA, Pieters R, Kremer LCM; International Childhood Cancer Outcome Project participants. van Kalsbeek RJ, et al. Nat Med. 2023 Jun;29(6):1340-1348. doi: 10.1038/s41591-023-02339-y. Epub 2023 Jun 15. Nat Med. 2023. PMID: 37322119 Review.
700,000 years of tropical Andean glaciation.
Rodbell DT, Hatfield RG, Abbott MB, Chen CY, Woods A, Stoner JS, McGee D, Tapia PM, Bush M, Valero-Garcés BL, Lehmann SB, Mark SZ, Weidhaas NC, Hillman AL, Larsen DJ, Delgado G, Katz SA, Solada KE, Morey AE, Finkenbinder M, Valencia B, Rozas-Davila A, Wattrus N, Colman SM, Bustamante MG, Kück J, Pierdominici S. Rodbell DT, et al. Among authors: mark sz. Nature. 2022 Jul;607(7918):301-306. doi: 10.1038/s41586-022-04873-0. Epub 2022 Jul 13. Nature. 2022. PMID: 35831604 Free PMC article.
Nocturnal enuresis.
Mark SD, Frank JD. Mark SD, et al. Br J Urol. 1995 Apr;75(4):427-34. doi: 10.1111/j.1464-410x.1995.tb07259.x. Br J Urol. 1995. PMID: 7788250 Review.
Modern Active Surveillance in Prostate Cancer: A Narrative Review.
Pattenden TA, Samaranayke D, Morton A, Ong WL, Murphy DG, Pritchard E, Evans S, Millar J, Chalasani V, Rashid P, Winter M, Vela I, Pryor D, Mark S, Lawrentschuk N, Thangasamy IA. Pattenden TA, et al. Among authors: mark s. Clin Genitourin Cancer. 2023 Feb;21(1):115-123. doi: 10.1016/j.clgc.2022.09.003. Epub 2022 Sep 8. Clin Genitourin Cancer. 2023. PMID: 36443163 Review.
What Is a Cognitive Map? Organizing Knowledge for Flexible Behavior.
Behrens TEJ, Muller TH, Whittington JCR, Mark S, Baram AB, Stachenfeld KL, Kurth-Nelson Z. Behrens TEJ, et al. Among authors: mark s. Neuron. 2018 Oct 24;100(2):490-509. doi: 10.1016/j.neuron.2018.10.002. Neuron. 2018. PMID: 30359611 Free article. Review.
Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data Network.
Lorscheider J, Signori A, Subramaniam S, Benkert P, Vukusic S, Trojano M, Hillert J, Glaser A, Hyde R, Spelman T, Magyari M, Elberling F, Pontieri L, Koch-Henriksen N, Sørensen PS, Gerlach O, Prat A, Girard M, Eichau S, Grammond P, Horakova D, Ramo-Tello C, Roos I, Buzzard K, Lechner Scott J, Sánchez-Menoyo JL, Alroughani R, Prévost J, Kuhle J, Gray O, Mathey G, Michel L, Ciron J, De Sèze J, Maillart E, Ruet A, Labauge P, Zephir H, Kwiatkowski A, van der Walt A, Kalincik T, Butzkueven H; Italian MS Register; Observatoire Français de la Sclérose en Plaques (OFSEP); MSBase Study Group; Swedish MS Registry; Big MS Data Network. Lorscheider J, et al. J Neurol Neurosurg Psychiatry. 2025 May 14;96(6):606-615. doi: 10.1136/jnnp-2024-334700. J Neurol Neurosurg Psychiatry. 2025. PMID: 39643429 Free PMC article.
353 results